je.st
news
Tag: shire
Shire Said in Advanced Talks to Acquire Drugmaker Baxalta
2016-01-03 22:20:46| Biotech - Topix.net
Shire Plc is in advanced talks to acquire Baxalta Inc. for about $32 billion in cash and stock, excluding debt, according to people familiar with the matter. The two drugmakers may announce a deal as soon as this week, the people said, asking not to be identified as the matter isn't public.
Tags: advanced
talks
acquire
shire
Exclusive: Shire closer to deal to buy Baxalta - sources
2015-12-22 23:18:54| Biotech - Topix.net
Drug maker Shire Plc has made a new acquisition offer that is roughly in line with Baxalta International Inc's valuation expectations, making a deal in the coming weeks likely, according to people familiar with the matter. While the exact terms of the deal could not be learned, Shire has added enough cash to its previous all-stock offer for the negotiations to advance, the people said.
Tags: buy
deal
sources
exclusive
Shire PLC (SHPG) to Post FY2020 Earnings of $19.63 Per Share, Leerink Swann Forecasts
2015-12-19 08:55:01| Biotech - Topix.net
Equities research analysts at Leerink Swann issued their FY2020 EPS estimates for Shire PLC in a research note issued to investors on Tuesday, Zacks Investment Research reports. Leerink Swann analyst J. Gerberry forecasts that the firm will post earnings per share of $19.63 for the year.
Exclusive: Shire prepares to make new bid for Baxalta - source
2015-11-25 19:18:47| Biotech - Topix.net
The London-listed group has asked its advisers to renew its bid effort, the source said, almost four months after Baxalta rejected an unsolicited $30 billion offer that it said significantly undervalued the company. Shire's bid preparations come three weeks after it announced its $5.9 billion purchase of U.S. rare disease specialist Dyax Corp on the offer which could be structured in cash and shares, the source said, cautioning that no deal was certain and negotiations could still fall through.
Tags: make
source
exclusive
bid
Shire strikes $6.5 bn deal for US biotech firm Dyax Corp
2015-11-04 02:33:35| Biotech - Topix.net
Dublin-based drug maker Shire said it has struck an all-cash $6.5 billion deal for US biotech Dyax Corp., even as it chases a $30 billion deal for rare-disease rival Baxalta Inc. Dyax shareholders will receive an additional $4 a share if certain performance targets are met, which would increase the overall value of the deal by $646 million. Based in Burlington, Massachusetts, Dyax has specialized in the development of treatments for HAE, a rare genetic disease that can be life-threatening.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] next »